APA (7th ed.) Citation

J, W., A, L., D, T., L, C., C, C., A, D. L., . . . C, M. (2026). Targeting CDK4/6 in Combination with Phage-Based Anti-HER2 Vaccination Overcomes Immune Evasion and Enhances the Anticancer Response in Breast Cancer. Pharmaceutics, 18(7), . https://doi.org/10.3390/pharmaceutics18070881

Chicago Style (17th ed.) Citation

J, Wang, et al. "Targeting CDK4/6 in Combination with Phage-Based Anti-HER2 Vaccination Overcomes Immune Evasion and Enhances the Anticancer Response in Breast Cancer." Pharmaceutics 18, no. 7 (2026). https://doi.org/10.3390/pharmaceutics18070881.

MLA (9th ed.) Citation

J, Wang, et al. "Targeting CDK4/6 in Combination with Phage-Based Anti-HER2 Vaccination Overcomes Immune Evasion and Enhances the Anticancer Response in Breast Cancer." Pharmaceutics, vol. 18, no. 7, 2026, https://doi.org/10.3390/pharmaceutics18070881.